![]() |
市场调查报告书
商品编码
1949560
探针再处理市场-全球产业规模、份额、趋势、机会和预测:按分类、方法、类型、产品、最终用户、地区和竞争格局划分,2021-2031年Probe Reprocessing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Classification, By Method, By Type, By Product, By End User, By Region & Competition, 2021-2031F |
||||||
全球探针再处理市场预计将从 2025 年的 9.1103 亿美元大幅成长至 2031 年的 16.5397 亿美元,复合年增长率达 10.45%。
此市场领域涵盖用于可重复使用医疗探针(例如内视镜和超音波换能器)的灭菌、消毒和清洁所需的专用设备、服务和耗材,旨在防止交叉感染。推动该市场成长的主要因素是医院获得性感染 (HAI) 发生率的上升以及由此导致的严格感染控制法规的实施,这些法规要求医疗机构遵循标准化的消毒通讯协定。此外,全球诊断影像检查的快速成长也使得可靠且高效的再处理系统成为确保设备可用性和支援高患者吞吐量的关键。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 9.1103亿美元 |
| 市场规模:2031年 | 1,653,970,000 美元 |
| 复合年增长率:2026-2031年 | 10.45% |
| 成长最快的细分市场 | 半临界 |
| 最大的市场 | 北美洲 |
儘管存在这些有利因素,但市场仍面临着许多障碍,这些障碍源于製造商使用说明 (IFU) 差异所带来的合规负担和操作复杂性。这种复杂性常常导致程序错误和监管处罚。根据感染控制与流行病学专业人员协会 (APIC) 的数据,2024 年接受调查的感染负责人中,有 42% 的人表示其所在机构曾因在再处理过程中未遵守医疗设备製造商的使用说明而被处罚。这种合规差距凸显了严格遵守再处理标准所面临的挑战,这不仅增加了操作复杂性,还可能阻碍从手动再处理技术向自动化解决方案的快速过渡。
全球探头再处理市场的主要驱动力是超音波影像检查的日益普及。随着医疗机构不断满足对非侵入性诊断日益增长的需求,探头的使用量也不断增加,这需要快速可靠的再处理流程来确保设备的持续使用。对成像能力的强劲需求促使高效的消毒流程应能满足大量患者的消毒需求。 GE医疗于2025年2月发布的「2024年第四季及全年财务表现」报告显示,其年度总收入达197亿美元,这充分体现了这一规模,也凸显了诊断成像领域的显着增长,而这直接推动了对再处理设备和耗材的需求。
同时,市场正经历显着的转变,加速从人工消毒方法到自动化高级消毒的过渡。医疗机构正逐渐抛弃不稳定的人工浸泡消毒技术,转而采用能维持标准化流程并提升病人安全的自动化系统。这一趋势体现在旨在减少人为错误的技术的日益普及上。 Nanosonics 在 2025 年 8 月的年度报告中指出,全球自动化 trophon 消毒设备的装置容量已达 37,000 台。此外,为了进一步展示这些先进系统在预防感染方面的广泛应用,该公司还在 2025 年宣布,超音波探头再处理技术每年可保护约 2,800 万名患者免受交叉感染的风险。
全球探针再处理市场受到许多因素的限制,包括繁重的合规负担和因不同製造商使用说明(IFU)而导致的复杂操作流程。医疗机构必须执行针对不同探针型号的复杂消毒和清洁通讯协定,这阻碍了统一高效工作流程的建立。这种碎片化迫使各科室投入大量资源用于员工培训和人工监督,以防止操作失误。因此,这种低效率的操作流程降低了整体诊断检测量,抑制了对相关再处理耗材的需求,并延缓了新型高效能设备的引入。
严格的法规环境进一步阻碍了市场扩张,为医疗机构的扩充性设置了障碍。精确管理复杂流程所需的投入,往往导致资源转移到规避监管风险上,而非用于推动市场成长的技术投资。根据医疗设备促进协会 (AAMI) 预测,到 2024 年,约有三分之一的消毒处理部门将缺乏完善的消毒流程管理追踪系统。这种工作流程管理的重大缺陷凸显了营运障碍,限制了医疗机构采用先进的再处理解决方案的能力,最终减缓了整体市场的成长速度。
随着医疗机构从人工记录转向防篡改的自动化合规性追踪,审核软体与数位化追溯的整合正在从根本上改变市场格局。这一趋势包括引入具备连接性和内建RFID的再处理系统,这些系统能够自动记录循环参数,将特定探头与患者诊疗流程关联起来,确保即时准备接受审核。製造商正透过提供将数位化合规服务与设备维护结合的互联生态系统,从这项转型中获利。 Nanosonics在2025年8月发布的「2025年度报告」中指出,在数位化追溯解决方案和互联服务的推动下,其经常性收入年增20%,达到1.461亿美元。
同时,市场正经历重大的技术变革,从传统的化学消毒工作流程转向采用UV-C LED消毒技术。这一趋势的核心在于使用快速、无化学消毒的设备,利用紫外线对非腔内探针进行消毒,有效避免工作人员接触有害气体,并显着缩短设备週转时间。大量投资涌入这一领域,以支持环保平台的商业化,证实了其优于现有液体消毒系统的优势。为了支持这一发展势头,《生物世界》(BioWorld)2025年2月刊登了一篇报导“Germitec融资3000万美元,将UV-C消毒技术引入美国”的文章,报道了Germitec SA公司已成功资金筹措,用于加速其Chronos系统在美国市场的上市,该系统已获得监管部门核准。
The Global Probe Reprocessing Market is projected to expand significantly, rising from a valuation of USD 911.03 Million in 2025 to USD 1653.97 Million by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 10.45%. This market sector covers the specialized equipment, services, and consumables required to sterilize, disinfect, and clean reusable medical probes, including endoscopes and ultrasound transducers, to avert cross-contamination. The primary forces driving this growth include the rising incidence of hospital-acquired infections (HAIs) and the subsequent implementation of strict infection control regulations, which obligate healthcare institutions to follow standardized disinfection protocols. Furthermore, the global surge in diagnostic imaging procedures creates a critical need for reliable and efficient reprocessing systems to ensure equipment availability and support high patient throughput.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 911.03 Million |
| Market Size 2031 | USD 1653.97 Million |
| CAGR 2026-2031 | 10.45% |
| Fastest Growing Segment | Semi-critical |
| Largest Market | North America |
Despite these positive drivers, the market encounters substantial obstacles stemming from the compliance burden and operational intricacies linked to varying manufacturer instructions for use (IFUs). These complexities frequently result in procedural mistakes and regulatory penalties. Data from the Association for Professionals in Infection Control and Epidemiology indicates that in 2024, 42% of infection preventionists surveyed stated their facilities received citations for failing to follow medical device manufacturer IFUs during reprocessing. This gap in compliance highlights the challenges involved in strictly adhering to reprocessing standards, which complicates operations and potentially impedes the swift transition from manual reprocessing techniques to automated solutions.
Market Driver
A primary factor fueling the Global Probe Reprocessing Market is the escalating volume of ultrasound imaging procedures. As medical facilities aim to satisfy the rising demand for non-invasive diagnostics, the utilization rate of probes has increased, requiring fast and dependable reprocessing turnovers to ensure devices remain available for use. This intense demand for imaging capabilities necessitates efficient disinfection workflows capable of handling high patient volumes. Evidence of this scale is found in GE HealthCare's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025, where the company announced total annual revenues of $19.7 billion, highlighting the massive growth of the diagnostic imaging sector which directly drives the need for reprocessing equipment and consumables.
Concurrently, there is a marked shift in the market involving an accelerated transition from manual methods to automated high-level disinfection. Healthcare providers are progressively moving away from manual soaking techniques, which are susceptible to inconsistencies, opting instead for automated systems that uphold standardized compliance and improve patient safety. This trend is demonstrated by the growing adoption of technology specifically engineered to reduce human error. In its '2025 Annual Report' released in August 2025, Nanosonics noted that its global installed base of automated trophon disinfection units had reached 37,000. Furthermore, demonstrating the widespread infection prevention impact of these advanced systems, Nanosonics reported in 2025 that its ultrasound probe reprocessing technology protects approximately 28 million patients annually from the risks of cross-contamination.
Market Challenge
The Global Probe Reprocessing Market is significantly restrained by the heavy compliance burden and operational complexities associated with diverse manufacturer instructions for use (IFUs). Healthcare institutions must navigate a complicated array of distinct disinfection and cleaning protocols for various probe models, preventing the creation of a uniform, streamlined workflow. This fragmentation necessitates that departments dedicate a disproportionate amount of resources to staff training and manual oversight to prevent procedural errors. As a result, this operational inefficiency lowers the overall throughput of diagnostic exams, thereby curtailing the demand for related reprocessing consumables and delaying the acquisition of newer, more efficient equipment.
This strict regulatory environment further impedes market expansion by establishing barriers to scalability for healthcare organizations. The effort required to maintain precise control over these intricate processes frequently leads to resources being diverted toward regulatory risk mitigation rather than capital investments in technologies that could grow the market. According to the Association for the Advancement of Medical Instrumentation (AAMI), nearly one-third of sterile processing departments in 2024 reported lacking a tracking system sufficient for managing the sterilization process. This substantial deficiency in workflow management highlights the operational hurdles that limit the ability of facilities to implement advanced reprocessing solutions, ultimately slowing the market's overall growth trajectory.
Market Trends
The market is being fundamentally transformed by the integration of audit software and digital traceability, as healthcare facilities shift from manual documentation to tamper-proof, automated compliance tracking. This trend involves the adoption of reprocessing systems equipped with connectivity and built-in RFID to automatically record cycle parameters, thereby linking specific probes to patient procedures to guarantee immediate audit readiness. Manufacturers are increasingly generating revenue from this transition by providing connected ecosystems that combine digital compliance services with equipment maintenance. In its '2025 Annual Report' from August 2025, Nanosonics reported a 20% year-over-year increase in recurring revenue, reaching $146.1 million, driven by these digital traceability solutions and connected services.
In parallel, the market is seeing a major technological shift with the adoption of UV-C LED disinfection technologies, moving away from traditional chemical-based workflows. This trend centers on the use of rapid, chemical-free devices that employ ultraviolet light to disinfect non-lumened probes, effectively eliminating staff exposure to hazardous fumes and significantly shortening equipment turnaround times. This sector is drawing considerable investment to back the commercial launch of these eco-friendly platforms, confirming their viability against established liquid systems. Underscoring this momentum, a February 2025 article in BioWorld titled 'Germitec raises $30M to bring UV-C disinfection tech to US' reported that Germitec SA secured $30 million in funding specifically to hasten the U.S. commercialization of its Chronos system following regulatory clearance.
Report Scope
In this report, the Global Probe Reprocessing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Probe Reprocessing Market.
Global Probe Reprocessing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: